Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 07, 2013 8:30am EST

RXi Pharmaceuticals Announces $16.4 Million Placement of Common Stock

Mar 07, 2013 8:30am EST

RXi Pharmaceuticals and OPKO Health Announce Strategic Pooling of RNAi Assets

Mar 04, 2013 4:27pm EST

OPKO Health Completes Acquisition of Two Phase 3 Products

Mar 01, 2013 8:16am EST

OPKO Point-of-Care Technology Demonstrated on Mobile Device with Cloud Connectivity to Diagnose and Track Disease in Africa

Feb 15, 2013 4:27pm EST

OPKO Health Completes Acquisition of Brazilian Pharmaceutical Company

Feb 08, 2013 12:24pm EST

Clarification Regarding Exercise and Sale of Common Stock Options by OPKO Health Company Officer

Jan 31, 2013 8:00am EST

OPKO Closes Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Jan 25, 2013 8:02am EST

OPKO Prices Offering of $175 Million of 3.00% Convertible Senior Notes Due 2033

Jan 23, 2013 4:04pm EST

OPKO Announces Proposed Private Offering of $150 Million Convertible Senior Notes Due 2033

Jan 14, 2013 8:30am EST

OPKO Health Expands Collaboration with Bristol-Myers Squibb

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Page 46
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap